breast cancer - search results

HALO Diagnostics and breast imaging company Ikonopedia have inked a genetic testing partnership to improve breast cancer detection and outcomes.

A survey of patients with breast cancer conducted in five European countries found that four-in-five patients eligible for genomic testing are not told it is available to them.

A biomarker has been found that distinguishes whether ductal carcinoma in situ, a sometimes benign breast cancer, will become invasive.

In this analysis, the researcher included data from 160,500 women with breast cancer and more than 226,000 women of Asian and European ancestry.

Current guidelines generally recommend screening women at average risk for breast cancer 10 years earlier than a relative’s diagnosis age.

A potential therapeutic target for triple negative breast cancer (TNBC) has been pinpointed by researchers at Virginian Commonwealth University (VCU) Massey Cancer Center. Importantly, this target may be effective in black patients, who suffer disproportionally from the disease.

About one-quarter of of recurrent estrogen receptor–positive (ER+) breast cancers lose ER expression making them resistant to endocrine therapy say researchers from Baylor College of Medicine.

Spanish researchers demonstrate the ability of a new therapy to overcome a treatment resistance mechanism in HER2 positive breast cancer.

Previous studies have demonstrated higher rates of brain metastases in patients with inflammatory breast cancer, but detailed information is lacking.

A new study finds that the rate of breast cancer recurrence after nipple-sparing mastectomy (NSM) is low—only 3%—up to 10 years after treatment.